Delivery Order SPE2DB24D2100-SPE2DB25FBCME

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, with a ceiling value of $1,218.20 and a period of performance through October 25, 2024. This is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 15 MG NASAL SPRAYS. The contract has a ceiling value of $1,870.36 and an ultimate completion date of December 9, 2024. It is a firm-fixed-price contract, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALTOCO 10 MG NASAL SPRAYS, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $2,566.24 and runs through February 25, 2025. There is no set-aside designation, indicating open competition. AmerisourceBergen also holds a $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of VALTOCO 5 MG nasal sprays, with a ceiling value of $1,218.84 and a performance period through September 18, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for VALTOCO 10 MG NASAL SPRAYS, with a ceiling value of $4,962.24 and a period of performance through August 29, 2024. The contract is a Firm Fixed Price arrangement with no set-aside requirements. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 10 MG Nasal Sprays. The contract has a firm fixed price of $1,723.51 and an ultimate completion date of May 8, 2024. The award was made on May 7, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VALTOCO 10 MG NASAL SPRAYS. The delivery order has a ceiling value of $1,355.52 and a period of performance through February 6, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the delivery of VALTOCO 10 MG NASAL SPRAYS to the Defense Logistics Agency (DLA). The $2,107.43 firm fixed-price delivery order has a completion date of May 30, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a range of pharmaceutical products and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the purchase of VALTOCO 15 MG nasal sprays. The contract has a firm-fixed price of $2,505.80 and a completion date of September 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 10 MG nasal sprays. The award is a firm fixed-price contract, valued at $1,127.66, with a period of performance through August 21, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999, for delivering a wide range of medical...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBCME
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VALTOCO 10 MG NASAL SPRAYS. The contract has a ceiling value of $1,355.52 and runs through February 28, 2025. It is a firm-fixed-price contract, and there is no set-aside designation indicated.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/1/25, 3:11 AM